BL NANOBIOMED

Their core work

BL NANOBIOMED is a Greek technology SME based in Thessaloniki specializing in nanomaterials, organic electronics, and nano-characterization for advanced manufacturing. Their work covers the development and application of organic and printed electronic devices — including solar cells (OPVs), LEDs (OLEDs), and thin-film transistors (OTFTs) — produced via roll-to-roll and vapour-phase deposition processes. They also work on nano-functionalized surfaces applied to flexible plastics and paper, targeting packaging, permeation barrier coatings, and structural electronics. Their dual presence in characterization technology and sustainable nanomaterials positions them at the intersection of high-throughput manufacturing and green materials innovation.

What they specialise in

How they've shifted over time

BL NANOBIOMED entered H2020 with a focus on the manufacturing side of organic electronics — specifically, how to characterize and control nanoscale processes during high-speed roll-to-roll production of devices like OPVs and OLEDs. Their second project marks a clear thematic expansion: away from device fabrication and toward functional surface engineering, where the material itself (flexible plastic, paper) becomes the product, and sustainability, recyclability, and packaging become the core value propositions. While both projects share a nanomaterials backbone, the trajectory points from electronics-first toward materials-for-sustainability, reflecting a broader industry shift toward circular economy and green packaging.

BL NANOBIOMED is moving from process-focused electronics manufacturing toward sustainable nanomaterial applications in packaging and flexible surfaces — making them an increasingly relevant partner for green materials and circular economy consortia.

How they like to work

BL NANOBIOMED has participated exclusively as a consortium partner across both projects, with no coordinator roles — suggesting they contribute specialist technical expertise rather than leading project management or administration. Both projects were mid-to-large consortia (RealNano and FlexFunction2Sustain typically involve 10-20+ partners), indicating comfort working within complex multi-partner structures. Their 30 unique partners across 12 countries over just 2 projects suggests broad but shallow network exposure — they bring technical value without controlling the collaboration architecture.

BL NANOBIOMED has built connections with 30 unique partners across 12 countries through just 2 projects, reflecting the large multinational consortia typical of H2020 Innovation Actions and RIAs. Their network is European in scope, though no repeated partner patterns can be identified from this dataset.

What sets them apart

BL NANOBIOMED occupies a specific niche at the intersection of organic printed electronics and nano-surface engineering — combining process knowledge (vapour deposition, R2R printing) with materials characterization and emerging sustainability applications. As a private Greek SME in Thessaloniki, they are relatively rare: most organic electronics expertise in Southern Europe sits in universities, making BL NANOBIOMED a commercially-oriented technical partner with direct manufacturing relevance. Their name ("NANOBIOMED") also hints at biomedical ambitions not yet fully visible in the project record, which may represent untapped positioning for future health-sector consortia.

Highlights from their portfolio

• RealNano
  Addresses a concrete industrial bottleneck — real-time nano-characterization during high-speed R2R production — with direct relevance to scaling up organic electronics for automotive and biosensor markets.
• FlexFunction2Sustain
  Larger project scope (2020-2024) combining open innovation with nano-functionalized sustainable surfaces, positioning BL NANOBIOMED at the frontier of green packaging and flexible electronics convergence.